Comparative Pharmacology
Head-to-head clinical analysis: CHG SCRUB versus ORAQIX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHG SCRUB versus ORAQIX.
CHG SCRUB vs ORAQIX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate disrupts bacterial cell membranes, leading to leakage of intracellular contents and cell death. It also binds to proteins and inhibits bacterial enzymes.
Oraqix is a eutectic mixture of lidocaine and prilocaine that acts as a local anesthetic. It reversibly blocks sodium ion channels in nerve cell membranes, inhibiting the initiation and conduction of nerve impulses, thereby producing anesthesia.
Apply 5 mL to wet skin, scrub for 2 minutes, rinse thoroughly. Use undiluted.
750 mg orally once daily for 5 days; or 250 mg orally once daily for 5 days (levofloxacin equivalent).
None Documented
None Documented
Approximately 2 hours (terminal); prolonged in renal impairment.
Terminal elimination half-life: 7.5 hours (range 6-9 h) in patients with normal renal function; extends to 20-30 h in severe renal impairment (CrCl <30 mL/min), necessitating dose adjustment.
Primarily renal (90% unchanged); <5% biliary/fecal.
Renal: ~60% unchanged; biliary/fecal: ~30% as metabolites and parent drug; total clearance approximates renal clearance.
Category C
Category C
Antiseptic
Antiseptic